tiprankstipranks
Enveric Biosciences (DE:SLZA)
FRANKFURT:SLZA

Enveric Biosciences (SLZA) Financial Statements

1 Followers

Enveric Biosciences Financial Overview

Enveric Biosciences's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Enveric Biosciences is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is €-0.73. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -3.41M$ -2.82M$ -6.36M$ 5.03M$ -10.39M
EBITDA$ -3.33M$ -2.72M$ -6.24M$ 5.14M$ -10.31M
Net Income Common Stockholders$ -3.44M$ -2.82M$ -6.40M$ 5.15M$ -8.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.29M$ 4.27M$ 7.08M$ 12.56M$ 17.72M
Total Assets$ 4.30M$ 6.62M$ 9.80M$ 15.85M$ 19.55M
Total Debt$ 0.00$ 0.00$ 9.61K$ 37.04K$ 63.82K
Net Debt$ -2.29M$ -4.27M$ -7.07M$ -12.52M$ -17.66M
Total Liabilities$ 2.34M$ 4.18M$ 4.93M$ 4.30M$ 4.00M
Stockholders Equity$ 1.96M$ 2.44M$ 4.87M$ 10.41M$ 14.67M
Cash Flow-
Free Cash Flow$ -1.75M$ -2.74M$ -4.45M$ -5.14M$ -3.47M
Operating Cash Flow$ -1.75M$ -2.74M$ -4.47M$ -5.14M$ -3.46M
Investing Cash Flow$ -38.00$ 20.00$ 16.85K$ -5.17K$ -6.19K
Financing Cash Flow$ -186.08K$ -105.00K$ -1.05M-$ -1.00
Currency in USD

Enveric Biosciences Earnings and Revenue History

Enveric Biosciences Debt to Assets

Enveric Biosciences Cash Flow

Enveric Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis